XML 27 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-based Payments
6 Months Ended
Mar. 31, 2018
Share-based Payments  
Share-based Payments

 

9.Share-based Payments

 

The fair value of an outstanding employee stock option award is estimated on the date of grant. The expected term of the stock option granted represents the period of time the stock option expected to be outstanding. The risk-free interest rate is based on U.S. Treasury bond rates with maturities equal to the expected term of the stock option on the grant date. The Company uses historical data as a basis to estimate the probability of forfeitures.

 

Stock option activity for the six months ended March 31 was as follows:

 

 

 

2018

 

2017

 

 

 

Shares of stock
under options

 

Weighted average
exercise price

 

Shares of stock
under options

 

Weighted average
exercise price

 

 

 

(in millions)

 

 

 

(in millions)

 

 

 

Outstanding at September 30

 

0.7

 

$

31.11

 

0.9

 

$

30.36

 

Options granted

 

 

 

 

 

Options exercised

 

(0.1

)

27.79

 

(0.2

)

26.42

 

Options forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31

 

0.6

 

31.62

 

0.7

 

31.11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest in the future as of March 31

 

0.6

 

$

31.62

 

0.7

 

$

31.11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company grants stock units to employees under its Performance Earnings Program (PEP), whereby units are earned and issued dependent upon meeting established cumulative performance objectives and vest over a three-year service period. Additionally, the Company issues restricted stock units to employees which are earned based on service conditions. The grant date fair value of PEP awards and restricted stock unit awards is that day’s closing market price of the Company’s common stock. The weighted average grant date fair value of PEP awards were $37.69 and $38.16 during the six months ended March 31, 2018 and 2017, respectively. The weighted average grant date fair value of restricted stock unit awards were $36.91 and $38.05 during the six months ended March 31, 2018 and 2017, respectively. Total compensation expense related to share-based payments including stock options were $37.2 million and $38.1 million during the six months ended March 31, 2018 and 2017, respectively. Unrecognized compensation expense related to total share-based payments outstanding as of March 31, 2018 and September 30, 2017 was $133.5 million and $96.8 million, respectively, to be recognized on a straight-line basis over the awards’ respective vesting periods which are generally three years.